HEATHER MCFADDEN: Open Payments
NPI 1154668440 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,586 in 84 payments from 21 companies in 2025. Trend: 2023 $2,305 · 2024 $3,045 · 2025 $1,586
Food & beverage: $1,572Education: $14
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $184 |
| Arcutis Biotherapeutics, Inc. | 15 | $181 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $158 |
| Janssen Biotech, Inc. | 6 | $112 |
| LEO Pharma Inc. | 5 | $106 |
| Regeneron Healthcare Solutions, Inc. | 3 | $89 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| Novartis Pharmaceuticals Corporation | 5 | $83 |
| Galderma Laboratories, L.P. | 5 | $81 |
| Organogenesis Inc. | 3 | $76 |
Products named: Zoryve, SILIQ, TREMFYA, RINVOQ, COSENTYX, ADBRY, NEMLUVIO, CYGNUS DUAL.
Industry payments across OK — which companies pay providers there.
